<code id='88D6DF944D'></code><style id='88D6DF944D'></style>
    • <acronym id='88D6DF944D'></acronym>
      <center id='88D6DF944D'><center id='88D6DF944D'><tfoot id='88D6DF944D'></tfoot></center><abbr id='88D6DF944D'><dir id='88D6DF944D'><tfoot id='88D6DF944D'></tfoot><noframes id='88D6DF944D'>

    • <optgroup id='88D6DF944D'><strike id='88D6DF944D'><sup id='88D6DF944D'></sup></strike><code id='88D6DF944D'></code></optgroup>
        1. <b id='88D6DF944D'><label id='88D6DF944D'><select id='88D6DF944D'><dt id='88D6DF944D'><span id='88D6DF944D'></span></dt></select></label></b><u id='88D6DF944D'></u>
          <i id='88D6DF944D'><strike id='88D6DF944D'><tt id='88D6DF944D'><pre id='88D6DF944D'></pre></tt></strike></i>

          knowledge

          knowledge

          author:comprehensive    Page View:95
          Adobe

          Stoke Therapeutics is still seeking an effective dose for an experimental drug to treat a severe form of childhood epilepsy, following the release of updated data Tuesday that showed disappointing reductions in convulsive seizure activity.

          In the latest look at an ongoing mid-stage study, three monthly injections of the Stoke drug, called STK-001, given at a 45-mg dose, resulted in a median 18% reduction in convulsive seizure activity, compared to baseline.

          advertisement

          The new analysis was conducted on 16 children diagnosed with a rare form of epilepsy called Dravet syndrome. Last November, in six patients, the drug showed a median 55% reduction in seizure activity.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          leisure time

          Heart attack and stroke risk calculators need revising
          Heart attack and stroke risk calculators need revising

          AdobeForbusyprimarycarephysicianslikeme,anannualphysicalwitha27-year-oldmaleisablessing.Sincewe’real

          read more
          Albert Bourla of Pfizer: worst biopharma CEO of 2023
          Albert Bourla of Pfizer: worst biopharma CEO of 2023

          HyacinthEmpinado/STATPfizeristhisyear’santi-EliLilly.IfDavidRicksisthebestbiopharmaCEOof2023,thenPfi

          read more
          Sports medicine is finally prioritizing gender equality
          Sports medicine is finally prioritizing gender equality

          MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha

          read more

          Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

          2:13TheZaporizhzhiaNuclearPowerPlantisshownoutsideEnerhodarintheZaporizhzhiaregion,Russian-controlle